AKRO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Akero Therapeutics (AKRO) Earnings Date & Reports

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AKRO is expected to report earnings to rise 2.02% to -100 cents per share on May 20

Akero Therapeutics AKRO Stock Earnings Reports

Q1'25

Est.

$-1.01

Q4'24

Beat

by $0.17

Q3'24

Missed

by $0.17

Q2'24

Beat

by $0.02

Q1'24

Est.

$-0.90

The last earnings report on February 28 showed earnings per share of -99 cents, beating the estimate of -115 cents. With 984.99K shares outstanding, the current market capitalization sits at 3.34B.

View a ticker or compare two or three

Compare

AKRO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AKRO
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for AKRO (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biotechnology company, which specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

601 Gateway Boulevard

Phone

+1 650 487-6488

Employees

Web

https://www.akerotx.com